The securities litigation firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the Delaware Chancery Court on behalf of all common stockholders of Cornerstone Therapeutics, Inc. (“Cornerstone” or the “Company”) (NASDAQ: CRTX). According to the complaint, under the terms of the proposed transaction, Chiesi Farmaceutici S.p.A. (collectively, with its affiliates, “Chiesi”) would acquire the outstanding shares of Cornerstone for $9.50 per share in cash. The complaint alleges that the proposed consideration agreed to by the defendants is unfair, and the proposed transaction is the result of an unfair process that fails to maximize stockholder value and is designed with unreasonable deal protection devices that serve to prevent other bidders from making a successful competing offer for the Company. If you currently own common stock of Cornerstone and would like to learn more about the class action lawsuit, you may email or call Brower Piven, who will, without obligation or cost to you, attempt to answer your questions. You may contact Brower Piven by email at email@example.com, by calling (410) 415-6616, or at Brower Piven, A Professional Corporation, 1925 Old Valley Road, Stevenson, Maryland 21153. Attorneys at Brower Piven have combined experience litigating securities and other class action cases of over 60 years.